Autor: |
de Juanes S; Genome Modifications and Carcinogenesis, German Cancer Research Center, Heidelberg, Germany., Epp N, Latzko S, Neumann M, Fürstenberger G, Hausser I, Stark HJ, Krieg P |
Jazyk: |
angličtina |
Zdroj: |
The Journal of investigative dermatology [J Invest Dermatol] 2009 Jun; Vol. 129 (6), pp. 1429-36. Date of Electronic Publication: 2009 Jan 01. |
DOI: |
10.1038/jid.2008.410 |
Abstrakt: |
12R-lipoxygenase (12R-LOX) represents a key enzyme of a recently identified eicosanoid pathway in the skin that plays an essential role in the establishment and/or maintenance of the epidermal barrier function. Genetic studies show that loss-of-function mutations in ALOX12B, encoding 12R-LOX, and in ALOXE3, encoding another closely related LOX involved in this pathway, are the second most common cause for autosomal recessive congenital ichthyosis (ARCI). To investigate the pathomechanism of ARCI and the function of 12R-LOX, we recently generated a 12R-LOX knockout model. 12R-LOX-deficient mice die rapidly after birth from severe barrier dysfunction without exhibiting an obvious cutaneous phenotype. Thus, we analyzed the adult phenotype of 12R-LOX(-/-) skin transplanted onto nude mice. 12R-LOX(-/-) skin develops an ichthyosiform appearance with thickening of the epidermis, hyperproliferation, hypergranulosis, focal parakeratosis, and severe hyperkeratosis. The adult mutant mouse skin phenotype closely reproduces the ichthyosis phenotype seen in patients with ALOX12B mutations. Western blot analysis revealed restoration of profilaggrin processing that used to be disturbed in neonatal mutant skin and overexpression of filaggrin, involucrin, and repetin. The results indicate that 12R-LOX knockout mice may represent a useful animal model for a detailed analysis of mechanisms involved in ARCI forms that are associated with impaired LOX metabolism. |
Databáze: |
MEDLINE |
Externí odkaz: |
|